NEW YORK (dpa-AFX) - The US bank JPMorgan has lowered its price target for Sartorius from 365 to 340 euros after the figures for the first quarter, but left the rating at "Overweight" due to the remaining share price potential. In view of the weak equipment orders, the annual targets of the pharmaceutical and laboratory supplier appear increasingly challenging, wrote analyst Richard Vosser in a study published on Monday. However, the recovery of the consumables business remains intact./mis/ajx

Publication of the original study: 19.04.2024 / 20:22 / BST

First release of the original study: 22.04.2024 / 00:15 / BST

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------